Clone MT2 has previously been described as anti-CD45RA but due to its reactivity with transfectants and its identical staining pattern with ORTH75E4, it is now recognised as anti-CD45RC. Clone MT2 reacts with membrane-bound antigen which is present on mature, non-activated T and B cells. It reacts with medullary thymocytes, with mantle zone lymphocytes in follicles of lymph nodes and spleen, with lymphocytes of the paracortex, with peripheral blood B cells, with T suppressor/cytotoxic cells and NK cells. This clone is used for differentiation of non-Hodgkin lymphomas.
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | MT2 |
| Source | Mouse |
| Tissue Type/Cancer Type | Tonsil |
| Pack | 6 mL – Manual – RTU, 100 Tests – Automation – i6000, 1 mL – Manual – Concentrate, 0.5 mL – Manual – Concentrate, 50 Tests – Automation – Xmatrx, 50 tests – NanoVIP®, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
